Fat loss still depends on overall calorie balance, activity level, and consistency
Data source, study protocol and patient selection Data for this investigation were accessed through the TriNetX Analytics platform, a global collaborative health research network widely used in numerous prominent epidemiological studies (Supplementary appendix) 43,44,45
Clinically meaningful responses in insulin-resistant patients typically include a reduction in fasting insulin of 20-40% and an improvement in HOMA-IR within 8-12 weeks at therapeutic doses, though individual variability is wide [1]
Getting that evaluation right requires a provider who understands the full picture: the hormonal drivers, the life stage, the metabolic history, and the long-term goals not just a BMI number
Members access regularly updated protocol recommendations based on the most recent clinical data, community experience, and expert analysis
Weeks 1-4: Foundation Phase The first four weeks establish whether you respond to AOD-9604 and whether the protocol suits your body